Concepedia

Kim Branson

KB

Statistics

Publications

16

Citations

823

H-Index

12

Active since

2003

Affiliations

Stanford University(Current)

GlaxoSmithKline (Netherlands)

GlaxoSmithKline (United States)

Queen Mary University of London

Science Oxford

Kim Branson is an author at Stanford University specializing in drug discovery, medicinal chemistry, and drug design.

Publications per year

2003–2025

16

Publications

16

Seminal Fluid Drives Expansion of the CD4+CD25+ T Regulatory Cell Pool and Induces Tolerance to Paternal Alloantigens in Mice1

Sarah A. Robertson, Leigh R. Guerin, John J. Bromfield et al. · Biology of Reproduction · 2009 · 345 citations · Full text

, , +13

The Virtual Laboratory: a toolset to enable distributed molecular modelling for drug design on the World‐Wide Grid

Rajkumar Buyya, Kim Branson, J. Giddy et al. · Concurrency and Computation Practice and Experience · 2003 · 116 citations

, , +16

Identification and Specificity Studies of Small-Molecule Ligands for SH3 Protein Domains

Steven R. Inglis, Cvetan Stojkoski, Kim Branson et al. · Journal of Medicinal Chemistry · 2004 · 74 citations · Full text

, , +16

Design of β-Amyloid Aggregation Inhibitors from a Predicted Structural Motif

Paul Novick, Dahabada H. J. Lopes, Kim Branson et al. · Journal of Medicinal Chemistry · 2012 · 58 citations · Full text

, , +17

mRNA codon optimization with quantum computers

Dillion M. Fox, Kim Branson, Ross C. Walker · PLoS ONE · 2021 · 40 citations · Full text

, , +12

1–5 of 16